Page 173 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 173

Title                      Overview of Study & Key Findings
                                  Evolution of Diabetes Care in Hong   (a) Demonstrates evidence in support of incorporating
                                  Kong: From the HKDR to JADE-    multi-component in the programme design for
                                  PEARL Program to RAMP and PEP   improving DM care in Hong Kong;
                                  Program (Ng et al., 2018)
                                                               (b) Highlights elements such as a team-based integrated
                                                                  care approach, information technological, and patient
                                                                  empowerment programs to substantially improve care
                                                                  provision and reduce incidence of diabetic
                                                                  complications, hospitalisation, and mortality;
                                                               (c) Calls for the strengthening of financing schemes through
                                                                  the adoption of PPP to provide integrated care as a
                                                                  feasible and cost-effective solution.
                                  Annual direct medical costs   (a) Estimated the direct medical costs associated with
                                  associated with diabetes-related   DM-related complications and observed a wide variation
                                  complications in the event year and   in estimated costs across major diabetic-related
                                  in subsequent years in Hong Kong   complications;
                                  (Jiao et al., 2017)
                                                               (b) Formulated a cost prediction model to enable economic
                                                                  evaluation of DM management programmes;
                                                               (c) Insightful for the cost-effectiveness analysis (CEA) for
                                                                  RAMP-DM care study (e.g., Jiao et al., 2018) to estimate
                                                                  cost-saved in reduction of DM associated complications.
                                  Effectiveness of the         (a) Assessed resultant development of three subtypes of
                                  multidisciplinary RAMP-DM for   diabetic microvascular complications over three years
                                  diabetic microvascular          follow-up in DM patients compared to those receiving
                                  complications: A population-based   regular primary care;
                                  cohort study (Jiao et al., 2016)   (b) Patients receiving RAMP-DM intervention were
                                                                  associated with a reduction in microvascular
                                                                  complications except in neuropathy over a three-year
                                                                  follow-up period.
                                  Long-term effects of the     (a) Assessed risks of cardiovascular complications and
                                  multidisciplinary RAMP-DM:      all-cause mortality in diabetic patients;
                                  A population-based cohort study   (b) Patients receiving RAMP-DM care by a multidisciplinary
                                  (Jiao et al., 2015)             team observed a reduction in occurrence of coronary
                                                                  heart disease (CHD), stroke, heart failure, total
                                                                  cardiovascular disease, and all-cause mortality;
                                                               (c) RAMP-DM intervention therefore is effective in the
                                                                  reduction of cardiovascular complications and all-cause
                                                                  mortality over three years follow-up.
                                  Evaluation of the quality of care of   (a) Highlights the importance of a multi-disciplinary
                                  multidisciplinary risk factor   team approach to DM care;
                                  assessment and management    (b) Forms the empirical basis for RAMP-DM care to be led
                                  programme for diabetic patients
                                  (Fung et al., 2012)             by a multi-disciplinary team;
                                                               (c) Calls for studies to evaluate the effectiveness of
                                                                  RAMP-DM care.





























                                                                                                               171
   168   169   170   171   172   173   174   175   176   177   178